Conferences
ASCO GU 2018: Management of Metastatic Disease for Adrenocortical Carcinoma and Pheochromocytoma
February 11, 2018
ASCO GU 2018: Timing and Patient Selection for Cytoreductive Nephrectomy
February 11, 2018
ASCO GU 2018: Management of Adrenocortical Carcinoma and Pheochromocytoma Endocrinologic Issues
February 11, 2018
ASCO GU 2018: Nivolumab Plus Ipilimumab Versus Standard of Care with Previously Untreated Unresectable or Metastatic Urothelial Carcinoma
February 11, 2018
ASCO GU 2018: Safety and Efficacy of Nivolumab in Metastatic Renal Cell Carcinoma: Results From the NIVOREN GETUG-AFU 26 Study
February 11, 2018
ASCO GU 2018: Subgroup Analysis of Progression-free Survival and Objective Response Rate in the Alliance AO31203 CABOSUN trial - Advanced Renal Cell Carcinoma
February 11, 2018
ASCO GU 2018: Impact of Medicaid Expansion on Diagnosis and Management of Patients with Testicular Cancer
February 11, 2018
ASCO GU 2018: Best of Journals: Kidney Cancer - Urology
February 11, 2018
ASCO GU 2018: Best of Journals: Kidney Cancer - Medical Oncology
February 11, 2018
ASCO GU 2018: Optimal Sequencing of First and Second Line Systemic Therapy in Metastatic Clear Cell Renal Cell Carcinoma
February 11, 2018
ASCO GU 2018: Status of Adjuvant Therapy in Renal Cell Carcinoma in 2018: Completed Trials and What Is Being Tested?
February 11, 2018
ASCO GU 2018: Optimal Imaging for the Indeterminate Renal Mass on CT: How to Determine What is Indeterminate
February 11, 2018
ASCO GU 2018: Targeting Bacteroides in the Stool Microbiome and Response to Treatment in Metastatic Renal Cell Carcinoma
February 11, 2018
ASCO GU 2018: Current Role of Metastasectomy in Renal Cell Carcinoma
February 11, 2018